A Population-Based Cohort Study Examining the Long-term Risk of Repeated Surgery in Non-Helicobacter pylori-Infected PPU Patients Who Underwent Simple Closure.
Perforated peptic ulcer
Recurrent perforation
Simple closure
Vagotomy
Journal
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
ISSN: 1873-4626
Titre abrégé: J Gastrointest Surg
Pays: United States
ID NLM: 9706084
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
11
04
2019
accepted:
21
10
2019
pubmed:
21
11
2019
medline:
15
4
2021
entrez:
21
11
2019
Statut:
ppublish
Résumé
The management of perforated peptic ulcer (PPU) has shifted from vagotomy/drainage to simple closure, followed by postoperative proton pump inhibitors (PPIs) and Helicobacter pylori (HP) eradication. Few studies have focused on the long-term impacts of this trend shift. We hypothesize that simple closure with PPIs is sufficient and does not carry an elevated rate of repeated surgery in non-HP-infected PPU patients. Hospitalized PPU patients who underwent simple closure or truncal vagotomy/pyloroplasty (TVP) in the National Health Insurance Research Database (NHIRD) from 2000 to 2008 were collected. The index date was defined as the date of ulcer admission. Patients who underwent other ulcer surgeries (e.g., gastrectomy, highly or selective vagotomy), who had a history of HP infection, or who were < 18 or > 100 years old were excluded. Additionally, the distributions of postoperative nonsteroidal anti-inflammatory drug (NSAID) and PPI use were calculated using the Longitudinal Health Insurance Database (LHID). After exclusion, a total of 66,413 patients were enrolled. There were 7232 (10.9%) patients who underwent TVP and 59,181 (89.1%) patients who underwent simple closure. The incidences of repeated ulcer-associated surgery were 5.10 and 23.05 versus 5.11 and 15.77 per 1000 person-years in the TVP cohort vs. the simple closure cohort before and after propensity score matching, respectively. When adjusted for age, sex, comorbidity, and Charlson comorbidity index score, the TVP cohort had a 68% (HR) and 66% (sHR) decreased risk compared with the simple closure cohort before propensity score matching, with a 67% decreased risk after propensity score matching in Cox proportional subdistribution hazard analysis and a 66% decreased risk in Fine-Gray proportional subdistribution hazard analysis. The LHID analysis showed a lower rate of postoperative NSAID use and a higher rate of postoperative PPI use in simple closure patients. Our findings suggest that in the Asian population, simple closure increases the risk of repeated ulcer-associated surgery in non-HP-infected PPU patients compared with TVP patients. However, further studies are warranted.
Identifiants
pubmed: 31745904
doi: 10.1007/s11605-019-04442-3
pii: 10.1007/s11605-019-04442-3
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2587-2595Références
Sung JJ, Kuipers EJ, El-Serag HB. Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther. 2009 May 1; 29(9):938-46.
Yuan Y, Padol IT, Hunt RH. Peptic ulcer disease today. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 80e9.
Medscape. Peptic ulcer disease. Accessed September 5, 2019. At https://www.medscape.com/answers/181753-13866/what-is-the-prevalence-of-peptic-ulcer-disease-pud-in-the-us .
Ramakrishnan K, Salinas RC. Peptic ulcer disease. Am Fam Physician. 2007; 76:1005-12.
University of Michigan Health System. Peptic ulcer disease. Accessed May 4, 2007, at: http://www.cme.med.umich.edu/pdf/guideline/PUD05.pdf .
Liang C-C, Muo C-H, Wang I-K, et al. (2014) Peptic Ulcer Disease Risk in Chronic Kidney Disease: Ten-Year Incidence, Ulcer Location, and Ulcerogenic Effect of Medications. PLoS ONE 9(2): e87952
Malfertheiner P, Chan FK, McColl KE. Peptic ulcer disease. Lancet. 2009 Oct 24; 374(9699):1449-61.
O’Connor A, Gisbert JP, O'Morain C, et al. Treatment of Helicobacter pylori Infection 2015. Helicobacter. 2015; 20 Suppl 1:54-61.
Treiber G, Wittig J, Ammon S, Walker S, van Doorn L, Klotz U. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study). Arch Intern Med 2002; 162:153-60.
Kuipers EJ, Thijs JC, Festen HP. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther. 1995; 9 Suppl 2:59-69.
Testerman TL, Morris J. Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment. World J Gastroenterol. 2014; 20(36):12781–12808.
Bertleff MJ, Lange JF. Perforated peptic ulcer disease: a review of history and treatment. Dig Surg. 2010; 27:161–169.
Lau JY, Sung J, Hill C, Henderson C, Howden CW, Metz DC. Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality. Digestion. 2011; 84:102–113.
Lagoo J, Pappas TN, Perez A. A relic or still relevant: the narrowing role for vagotomy in the treatment of peptic ulcer disease. Am J Surg. 2014; 207:120-6.
Miwa H, Sakaki N, Sugano K, et al. Recurrent peptic ulcers in patients following successful Helicobacter pylori eradication: a multicenter study of 4940 patients. Helicobacter. 2004 Feb; 9(1):9-16.
Ng EK, Lam YH, Sung JJ, et al. Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation: randomized controlled trial. Ann Surg. 2000; 231:153-158.
Nyhus LM, Baker RJ, Fischer JE. Mastery of surgery. 3rd ed. Boston:Little, Brown; 1997.
Søreide K, Thorsen K, Harrison EM, et al. Perforated peptic ulcer. Lancet. 2015; 386(10000):1288-98.
Wong CS, Chia CF, Lee HC, et al. Eradication of Helicobacter pylori for prevention of ulcer recurrence after simple closure of perforated peptic ulcer: a meta-analysis of randomized controlled trials. J Surg Res 2013; 182: 219–26.
Yang YX, Lewis JD, Epstein S, et al. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 2006; 296:2947–53.
Ngamruengphong S, Leontiadis G, Radhi S, Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies. Am J Gastroenterol. 2011 Jul;106(7):1209-18
Lin SM, Yang SH, Liang CC, et al. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study. Osteoporos Int. 2018 Jan; 29(1):153-162.
Peng YC, Huang LR, Lin CL, et al. Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD. Gut. 2018 Feb 22. pii: gutjnl-2018-316057. https://doi.org/10.1136/gutjnl-2018-316057
Chien LN, Huang YJ, Shao YH, et al. Proton pump inhibitors and risk of periampullary cancers--A nested case-control study. Int J Cancer. 2016 Mar 15; 138(6):1401-9.
Parsons LS. Performing a 1: N case-control match on propensity score. In: Proceedings of the 29th Annual SAS Users Group International Conference; May 9-12, 2004; Montreal, Canada
Hu WS, Lin CL. Risk of Atrial Fibrillation in Patients with Congenital Heart Disease: Results of a Propensity Score-Matched, Nationwide Cohort Study. J Atheroscler Thromb. 2019 Jul 1;26(7):670-677.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Chronic Dis. 1987; 40(5):373-83.
Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992 Jun; 45(6):613-9.
Nada T, Nomura M, Iga A,et al. Autonomic nervous function in patients with peptic ulcer studied by spectral analysis of heart rate variability. J Med. 2001; 32(5-6):333-47.
Yukinaka M, Nomura M, Saijyo T, et al. Evaluation of autonomic nervous function in patients with essential hypertension complicated with peptic ulcer. J Gastroenterol Hepatol. 2000; 15:40-4.
Cho CH, Qui BS, Bruce IC. Vagal hyperactivity in stress induced gastric ulceration in rats. J Gastroenterol Hepatol. 1996; 11:125-8.
Wu SC, Chen WT, Fang CW, et al. Association of vagus nerve severance and decreased risk of subsequent type 2 diabetes in peptic ulcer patients: An Asian population cohort study. Medicine (Baltimore). 2016 Dec; 95(49):e5489.
Wu SC, Fang CW, Chen WT, et al. Acid-reducing vagotomy is associated with reduced risk of subsequent ischemic heart disease in perforated peptic ulcer: An Asian population study. Medicine (Baltimore). 2016 Dec; 95(50):e5651.
Fang CW, Tseng CH, Wu SC, et al. Association of Vagotomy and Decreased Risk of Subsequent Ischemic Stroke in Perforated peptic ulcer Patients: an Asian Population Study. World J Surg. 2017 Dec;41(12):3171-3179
Cheng TJ, Guo HR, Chang CY, et al. The Association Between Peptic Ulcer Disease and Ischemic Stroke: A Population-Based Longitudinal Study. Medicine (Baltimore). 2016 May; 95(22):e3797.
Arai I, Hirose H, Muramatsu M, et al. Possible involvement of non-steroidal anti-inflammatory drugs in vagal-mediated gastric acid secretion in rats. Jpn J Pharmacol. 1985 Jan; 37(1):91-9.
Mulholland MW, Doherty G. Complications in surgery. Philadelphia, PA: Lippincott Williams & Wilkins; 2006.
Adami HO, Enander LK, Enskog L, et al. Recurrences 1 to 10 years after highly selective vagotomy in prepyloric and duodenal ulcer disease. Frequency, pattern, and predictors. Ann Surg 1984; 199:393–9.
Laniado-Laborín R. Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century. Int J Environ Res Public Health. 2009;6(1):209–224. doi: https://doi.org/10.3390/ijerph6010209
doi: 10.3390/ijerph6010209
Zhou Y, Boudreau DM, Freedman AN. Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population. Pharmacoepidemiol Drug Saf. 2014 Jan; 23(1):43-50.
Musumba C, Jorgensen A, Sutton L, et al. The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010. Aliment Pharmacol Ther. 2012 Jul; 36(1):48-56.
Wu CY, Wu MS, Kuo KN, Wang CB, Chen YJ, Lin JT. Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients. J Clin Oncol. 2010 Jun 20; 28(18):2952-7.
Rotman SR, Bishop TF. Proton pump inhibitor use in the U.S. Ambulatory Setting, 2002–2009. PLoS One 2013; 8:e56060.
Tennant SM, Hartland EL, Phumoonna T, et al. Influence of gastric acid on susceptibility to infection with ingested bacterial pathogens. Infect Immun 2008; 76:639–45.
Graham DY, Genta RM. Long term proton pump inhibitor use and gastrointestinal cancer. Curr Gastroenterol Rep 2008; 10:543–7.
Ohnishi S, Ma N, Thanan R, et al. DNA damage in inflammation-related carcinogenesis and cancer stem cells. Oxid Med Cell Long 2013; 2013:387014.
Schroder VT, Pappas TN, Vaslef SN, et al. Vagotomy/drainage is superior to local oversew in patients who require emergency surgery for bleeding peptic ulcers. Ann Surg. 2014 ;259(6):1111-8